We are live on ! Find out more
MEDP icon

Medpace

268 hedge funds and large institutions have $2.1B invested in Medpace in 2020 Q1 according to their latest regulatory filings, with 52 funds opening new positions, 85 increasing their positions, 98 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

68% more first-time investments, than exits

New positions opened: 52 | Existing positions closed: 31

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

42% more call options, than puts

Call options by funds: $5.06M | Put options by funds: $3.56M

7% more funds holding

Funds holding: 250268 (+18)

1.21% less ownership

Funds ownership: 80.49%79.28% (-1.2%)

13% less repeat investments, than reductions

Existing positions increased: 85 | Existing positions reduced: 98

14% less capital invested

Capital invested by funds: $2.43B → $2.1B (-$332M)

Holders
268
Holders Change
+18
Holders Change %
+7.2%
% of All Funds
5.89%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
52
Increased
85
Reduced
98
Closed
31
Calls
$5.06M
Puts
$3.56M
Net Calls
+$1.49M
Net Calls Change
+$2.86M

MEDP Hedge Fund Activity: Q1 2020 in Review

268 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in Medpace (MEDP) for Q1 2020, worth a combined $2.1B — down 14% from $2.43B a quarter earlier.

Buyers outnumbered sellers: 52 funds opened new MEDP positions and 31 closed out — a net gain of 21 holders — while 85 added to existing stakes and 98 trimmed.

The largest buyer was Wasatch Advisors, adding an estimated $42.1M. The largest seller was APG Asset Management, cutting an estimated $35M.

  • 268 institutional investors held Medpace (MEDP) as of Q1 2020, up from 250 in Q4 2019.
  • Funds reported $2.1B of Medpace stock for Q1 2020, down 14% quarter-over-quarter.
  • 52 funds opened new Medpace positions in Q1 2020 and 31 closed out, a net change of +21 holders.
  • The largest Medpace buyer in Q1 2020 was Wasatch Advisors, an estimated $42.1M added.
  • The largest Medpace seller in Q1 2020 was APG Asset Management, an estimated $35M sold.

Based on aggregated 13F filings for Q1 2020.